Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter�…
Objective.—To evaluate the efficacy and safety of anti—tumor necrosis factor α monoclonal
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design�…
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design�…
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter�…
E Abraham, R Wunderink, H Silverman, TM Perl… - 1995 - cabidigitallibrary.org
A randomized, prospective, multicentre, double-blind, placebo-controlled clinical trial was
used to evaluate the efficacy and safety of anti-tumour necrosis factor α monoclonal antibody�…
used to evaluate the efficacy and safety of anti-tumour necrosis factor α monoclonal antibody�…
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter�…
E Abraham, R Wunderink, H Silverman, TM Perl…�- …, 1995 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of anti-tumor necrosis factor alpha monoclonal
antibody (TNF-alpha MAb) in the treatment of patients with sepsis syndrome. Design�…
antibody (TNF-alpha MAb) in the treatment of patients with sepsis syndrome. Design�…
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter�…
E Abraham, R Wunderink, H Silverman, TM Perl…�- JAMA, 1995 - europepmc.org
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients
with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha�…
with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha�…
[CITATION][C] Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double�…
E Abraham, R Wunderink, H Silverman…�- JAMA: The Journal�…, 1995 - pure.johnshopkins.edu
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With
Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial — Johns�…
Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial — Johns�…
[CITATION][C] Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double�…
E Abraham, R Wunderink…�- …�: The Journal of�…, 1995 - scholars.northwestern.edu
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With
Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial�…
Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial�…
[CITATION][C] Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double�…
E Abraham, R Wunderink…�- …�: The Journal of�…, 1995 - utsouthwestern.elsevierpure.com
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients
With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial�…
With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial�…
[CITATION][C] Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome
E Abraham�- JAMA, 1995 - cir.nii.ac.jp
Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients
With Sepsis Syndrome | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ]�…
With Sepsis Syndrome | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ]�…
[CITATION][C] Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind�…
E ABRAHAM, R WUNDERINK…�- JAMA, the journal of�…, 1995 - pascal-francis.inist.fr
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with
sepsis syndrome : a randomized, controlled, double-blind, multicenter clinical trial CNRS Inist�…
sepsis syndrome : a randomized, controlled, double-blind, multicenter clinical trial CNRS Inist�…
[CITATION][C] Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind�…
E Abraham�- JAMA: The Journal of the American Medical�…, 1995 - cir.nii.ac.jp
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients
with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha�…
with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha�…